Intermittent fasting not linked to more weight loss than taking regular meals: JAMA

Written By :  Dr Satabdi Saha
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2020-09-29 11:02 GMT   |   Update On 2020-09-29 11:02 GMT

Fasting for two-thirds of the day does not lead to greater weight loss than eating meals throughout the day, according to a randomized trial published in JAMA Internal Medicine.Current guidelines recommend continuous energy restriction (CER) along with a comprehensive lifestyle intervention as the cornerstone of obesity treatment, yet this approach produces modest weight loss on...

Login or Register to read the full article

Fasting for two-thirds of the day does not lead to greater weight loss than eating meals throughout the day, according to a randomized trial published in JAMA Internal Medicine.

Current guidelines recommend continuous energy restriction (CER) along with a comprehensive lifestyle intervention as the cornerstone of obesity treatment, yet this approach produces modest weight loss on average. Recently, there has been increased interest in identifying alternative dietary weight loss strategies that involve restricting energy intake to certain periods of the day or prolonging the fasting interval between meals (i.e., intermittent energy restriction, IER). These strategies include intermittent fasting (IMF; >60% energy restriction on 2–3 days per week, or alternate days) and time-restricted feeding (TRF; limiting the daily period of food intake to 8–10 h or less on most days of the week).

The term time-restricted feeding (TRF) is used as a subcategory of IMF to describe "an eating pattern in which food intake is restricted to a time window of 8 h or less every day".

As the efficacy and safety of time-restricted eating have not been explored in large randomized clinical trials, a group of researchers conducted this clinical trial to ascertain the effect of time-restricted eating on weight loss and metabolic health in patients with overweight and obesity.

This randomized clinical trial looked at the effect on weight loss and metabolic health of restricting eating to between 12 p.m. and 8 p.m. among overweight and obese individuals.

Roughly 100 overweight or obese adults were assigned to time-restricted eating or consistent meal timing. In the time-restricted group, participants were advised to eat as needed from 12 p.m. until 8 p.m., and then fast for 16 hours until 12 p.m. the next day. In the consistent-meals group, participants were told to eat three structured meals across the day, with snacks as needed. There were no recommendations about caloric intake or physical activity.

This 12-week randomized clinical trial including men and women aged 18 to 64 years with a body mass index (BMI, calculated as weight in kilograms divided by height in meters squared) of 27 to 43 was conducted on a custom mobile study application.

The primary outcome assessed was weight loss. Secondary outcomes from the in-person cohort included changes in weight, fat mass, lean mass, fasting insulin, fasting glucose, hemoglobin A1c levels, estimated energy intake, total energy expenditure, and resting energy expenditure.

On analysis, the following facts were highlighted.

  • At 12 weeks, mean weight loss did not differ significantly between the groups (0.94 kg with time-restricted eating and 0.68 kg with consistent meals).
  • Most secondary outcomes, including changes in fat mass, lipids, and fasting glucose, also did not differ significantly between the groups.
  • Of note, the time-restricted group lost more appendicular lean mass than the consistent-meals group.

"Time-restricted eating, in the absence of other interventions, is not more effective in weight loss than eating throughout the day." wrote the team.

For the full article follow the link: 10.1001/jamainternmed.2020.4153

Primary source: JAMA Internal Medicine

Tags:    
Article Source : JAMA Internal Medicine

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News